CTRI/2018/12/016743Recruiting未知
A Prospective, Single-arm, Open labeled, multi-centric, observational, real-world evidence gathering study to evaluate benefits of supplementation of Lactobacillus reuteri DSM 17938 in full term infants with infantile colic
Global Generics India Dr Reddys Laboratories Limited0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1.Age: from birth to 5 months of age
- •2.Diagnosed with infantile colic using Rome IV Criteria (Infant has cried or fussed for 3 or more hours per day, during 3 or more days in the preceding week) and recommended with nutritional supplementation of Lactobacillus reuteri for infantile colic by the treating physician
- •3.Full term infant, i.e. gestational age between 37 and 42 weeks
- •4.Breast fed, either exclusively or predominantly, i.e. more than 50% time
- •5.Birth weight >2500g
- •6.Apgar score >= 8 at 5 minutes at birth
- •7.Written informed consent from parents to share data as per protocol and adhere to routine follow up visits as required by treating physician
- •8.Parent(s) willing to maintain same infant feeding mode throughout study period
- •9.Parent(s) willingness and ability to fill in diary and questionnaires
Exclusion Criteria
- •1.Significant co-existing illness or major medical problem, which in opinion of treating physician does not make patient suitable for participation in study
- •2.Any other gastrointestinal disorder
- •3.Failure to thrive
- •4.Use of antibiotics two weeks before enrolment and throughout the intervention period, for both infant and mother
- •5.Use of probiotics two weeks before enrolment and throughout the intervention period, for both infant (infant formula and/or supplementation) and mother
- •6.Use of acid suppressive therapy two weeks before enrolment and throughout the intervention period.
- •7.Infant receiving solid foods, such as cereals, mashed fruits or vegetable puree
- •8.Participation in any other interventional study
Investigators
Similar Trials
Completed
Phase 4
Effectiveness of Restylane® used for treatment of facial wrinkles, facial folds, volume loss and lips augmentation.CTRI/2017/09/009848Galderma India Pvt Ltd100
Active, not recruiting
Phase 4
Safety and Efficacy of Idursulfase in Idursulfase naive Indian patients for treatment of Mucopolysaccharidosis Type II (MPS II or Hunter Syndrome)CTRI/2022/03/041431Shire Biotech India Pvt Ltd
Completed
Not Applicable
A Study to find out the Effectiveness andSafety of Isoxsuprine Hydrochloride in Women with Preterm Labor in IndiaCTRI/2020/01/022643Abbott India Ltd170
Completed
Phase 4
A Study to Assess safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants with DiabetesCTRI/2020/07/026539Johnson and Johnson Private Limited276
Recruiting
Not Applicable
Study of bortezomib/dexamethasone therapy in patients with relapsed and/or refractory cutaneous T-cell lymphomaKCT0002953Samsung Medical Center32
